Cargando…

RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes

Severe coronavirus disease 2019 (COVID-19) is characterized by symptoms of lymphopenia and multiorgan damage, but the underlying mechanisms remain unclear. To explore the function of N6-methyladenosine (m6A) modifications in COVID-19, we performed microarray analyses to comprehensively characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Yuting, Zhang, Qiong, Wang, Kaihang, Zhang, Xujun, Yang, Rongwei, Bi, Kefan, Chen, Wenbiao, Diao, Hongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298984/ https://www.ncbi.nlm.nih.gov/pubmed/34301919 http://dx.doi.org/10.1038/s41419-021-04012-z

Ejemplares similares

MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review
por: Bi, Kefan, et al.
Publicado: (2020)

In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19
por: Zhang, Qiong, et al.
Publicado: (2021)

Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance
por: Chen, Wenbiao, et al.
Publicado: (2020)

Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis
por: Chen, Wenbiao, et al.
Publicado: (2021)

RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
por: Cai, Xianlei, et al.
Publicado: (2021)

N(6)-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
por: Wang, Tianyu, et al.
Publicado: (2022)

Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response
por: Zhang, Qiong, et al.
Publicado: (2022)

Osteopontin Exacerbates High-Fat Diet-Induced Metabolic Disorders in a Microbiome-Dependent Manner
por: Chen, Jianing, et al.
Publicado: (2022)

N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)

Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19
por: Zhang, Yongting, et al.
Publicado: (2022)

RBM15 condensates modulate m(6)A modification of STYK1 to promote tumorigenesis
por: Jiang, Amin, et al.
Publicado: (2022)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
por: Zhang, Xujun, et al.
Publicado: (2021)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Phospholipid metabolites of the gut microbiota promote hypoxia-induced intestinal injury via CD1d-dependent γδ T cells
por: Li, Yuyu, et al.
Publicado: (2022)

Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish
por: Hu, Liang, et al.
Publicado: (2020)

RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA
por: Zhang, Shouyi, et al.
Publicado: (2023)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
por: Du, Bingying, et al.
Publicado: (2021)

The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity
por: Zhang, Xujun, et al.
Publicado: (2020)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network
por: Chen, Wenbiao, et al.
Publicado: (2019)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases
por: Wang, Yuting, et al.
Publicado: (2023)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer’s Disease
por: Zhang, Runjiao, et al.
Publicado: (2022)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

Mechanisms of N6-methyladenosine modification in tumor development and potential therapeutic strategies (Review)
por: Pu, Xi, et al.
Publicado: (2023)

N(6)-methyladenosine modification—a key player in viral infection
por: Zhang, Xiaoyue, et al.
Publicado: (2023)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma
por: Wu, Yaohai, et al.
Publicado: (2023)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msg6fmcl7qp64itoeuuhkbrlnv